Coffee consumption linked to reduced liver fibrosis in people with HBV, HCV and NAFLD
High HCV cure rate demonstrated for people retreated after failure of short course direct-acting antiviral therapy
Triple DAA regimen cures hepatitis C patients with rapid response in just 3 weeks
Clinical impact of effective HCV DAAs: referrals for liver transplant drop after their introduction
Study reveals potential challenges for scaling up of HCV therapy in UK
Liver fibrosis improves after successful treatment for hepatitis C
Daclatasvir and sofosbuvir with ribavirin cures 90% of people with genotype 3 hepatitis C
Daclatasvir plus sofosbuvir works well for people with genotype 3 hepatitis C and advanced liver disease in real-world clinical practice
Tenofovir during pregnancy reduces risk of mother-to-child hepatitis B virus transmission
